Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119929) titled 'A prospective silent trial of using digital pathology-based artificial intelligence model to predict key genomic alterations in breast cancer to guide next-generation sequencing' on March 5.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Fudan University Shanghai Cancer Center
Condition:
Breast Cancer
Intervention:
NGS-recommended group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-05
Target Sample Size: NGS-recommended group:56;Non-NGS-recommended group:224;
Countries of Recruitment:
China
To know more, visit https://www.chictr...